Daily E-cigarette Use and the Surge in JUUL Sales: 2017-2019.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 Jun 2022
Historique:
accepted: 17 02 2022
medline: 3 11 2023
pubmed: 1 6 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

To identify how the 2017 rapid surge in sales of JUUL e-cigarettes affected usage among US youth and young adults. Annual surveys in the Population Assessment of Tobacco and Health Study assess tobacco use by product and brand among the US population. We identified 2 cohorts aged 14 to 34 years, 1 with baseline survey in 2014 before the rapid surge of JUUL and the other in 2017 as the surge in JUUL sales was occurring. For 5 age groups, we compared 2-year incidence of first tobacco use and of new-onset daily tobacco use by product, and report levels of dependence. Sociodemographic variables and rates of experimentation with any tobacco product were similar between cohorts. Among baseline nondaily tobacco users, only those aged 14 to 17 years had an increase in the 2-year incidence of new daily tobacco use (2014 cohort = 4.8%, 95% confidence interval 4.3, 5.5 vs 2017 cohort = 6.3%, 95% confidence interval 5.8-7.0) to rates approaching those in the 1990s. In 2019, three-quarters of new daily tobacco users aged 14 to 17 vaped daily and had e-cigarette dependence scores similar to daily cigarette smokers and older adult e-cigarette vapers. We estimate that about 600 000 Americans aged <21 years used JUUL products daily in 2019, a rate 2.5 times those aged 25 to 34 years. The surge in US JUUL sales was associated with a sharp rise in daily e-cigarette vaping and daily tobacco use among US youth, not young adults.

Identifiants

pubmed: 35634883
pii: 188151
doi: 10.1542/peds.2021-055379
pmc: PMC9647987
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R01 CA234539
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP000965
Pays : United States
Organisme : ACL HHS
ID : U01IP000965
Pays : United States

Informations de copyright

Copyright © 2022 by the American Academy of Pediatrics.

Auteurs

John P Pierce (JP)

Herbert Wertheim School of Public Health and Human Longevity Science.
Moores Cancer Center.

Jasen Zhang (J)

Herbert Wertheim School of Public Health and Human Longevity Science.

Laura E Crotty Alexander (LE)

School of Medicine, Division of Pulmonary Critical Care & Sleep.
Section of Pulmonary Critical Care, Veteran's Administration San Diego Healthcare System, San Diego, California.

Eric C Leas (EC)

Herbert Wertheim School of Public Health and Human Longevity Science.

Sheila Kealey (S)

Moores Cancer Center.

Martha M White (MM)

Moores Cancer Center.

David R Strong (DR)

Herbert Wertheim School of Public Health and Human Longevity Science.
Moores Cancer Center.

Dennis R Trinidad (DR)

Herbert Wertheim School of Public Health and Human Longevity Science.

Sara B McMenamin (SB)

Herbert Wertheim School of Public Health and Human Longevity Science.

Ruifeng Chen (R)

Herbert Wertheim School of Public Health and Human Longevity Science.

Tarik Benmarhnia (T)

Scripps Institution of Oceanography, University of California San Diego, San Diego, California.

Karen Messer (K)

Herbert Wertheim School of Public Health and Human Longevity Science.
Moores Cancer Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH